Your browser doesn't support javascript.
loading
A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy.
Tofthagen, Cindy; Tanay, Mary; Perlman, Adam; Starr, Jason; Advani, Pooja; Sheffield, Katharine; Brigham, Tara.
Afiliación
  • Tofthagen C; Division of Nursing Science, Mayo Clinic, Jacksonville, FL 32224, USA.
  • Tanay M; Faculty of Nursing, Midwifery and Palliative Care, King's College London, London SE1 8WA, UK.
  • Perlman A; Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL 32224, USA.
  • Starr J; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.
  • Advani P; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.
  • Sheffield K; Division of Nursing Science, Mayo Clinic, Jacksonville, FL 32224, USA.
  • Brigham T; Mayo Clinic Libraries, Mayo Clinic, Jacksonville, FL 32224, USA.
J Clin Med ; 11(2)2022 Jan 12.
Article en En | MEDLINE | ID: mdl-35054049
Chemotherapy induced peripheral neuropathy (CIPN) is a dose-limiting side effect of chemotherapy for which no prevention or cure exists. Cancer and cancer treatments can adversely affect nutritional status. Nutrition may play a role in development of CIPN, yet the relationship between nutrition and CIPN is not well understood. Common laboratory values measuring various aspects of nutrition (hemoglobin/hematocrit, vitamin B12, calcium, and magnesium) may be associated with CIPN. The aim of this systematic review is to evaluate the empirical evidence surrounding the relationship between laboratory measures of nutrition and CIPN among persons with cancer who received neurotoxic chemotherapy drugs. We conducted an extensive review of the literature to identify articles that evaluated relationships between laboratory measures of nutrition and CIPN. A total of eleven articles satisfied the inclusion/exclusion criteria. Participants in the studies had breast or colorectal cancer, lymphoma or multiple myeloma and were receiving a variety of neurotoxic drugs. Hemoglobin/hematocrit, vitamin D, albumin, and magnesium were associated with CIPN. The quality of the studies ranges from fair to good. Evidence suggests that low levels of the above-mentioned tests could be associated with CIPN but additional research is needed.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Systematic_reviews Idioma: En Revista: J Clin Med Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Systematic_reviews Idioma: En Revista: J Clin Med Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza